These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 28540756)
1. Nonadjunctive Use of Continuous Glucose Monitors for Insulin Dosing: Is It Safe? Shapiro AR J Diabetes Sci Technol; 2017 Jul; 11(4):833-838. PubMed ID: 28540756 [TBL] [Abstract][Full Text] [Related]
2. Commentary Regarding Shapiro, "Nonadjunctive Use of Continuous Glucose Monitors for Insulin Dosing: Is It Safe?". Price D J Diabetes Sci Technol; 2017 Jul; 11(4):839-841. PubMed ID: 28654305 [TBL] [Abstract][Full Text] [Related]
4. Assessing sensor accuracy for non-adjunct use of continuous glucose monitoring. Kovatchev BP; Patek SD; Ortiz EA; Breton MD Diabetes Technol Ther; 2015 Mar; 17(3):177-86. PubMed ID: 25436913 [TBL] [Abstract][Full Text] [Related]
5. The Safety of Nonadjunctive Use of Continuous Glucose Monitors for Insulin Dosing: Still Not Resolved. Shapiro AR J Diabetes Sci Technol; 2017 Jul; 11(4):856-857. PubMed ID: 28420260 [No Abstract] [Full Text] [Related]
6. FDA Approval of Nonadjunctive Use of Continuous Glucose Monitors for Insulin Dosing: A Potentially Risky Decision. Shapiro AR JAMA; 2017 Oct; 318(16):1541-1542. PubMed ID: 28910454 [No Abstract] [Full Text] [Related]
7. Retrospective Analysis of Continuous Glucose Monitoring Data With the Surveillance Error Grid Supports Nonadjunctive Dosing Decisions. Welsh JB; Walker T; Price D J Diabetes Sci Technol; 2017 Sep; 11(5):942-946. PubMed ID: 28617187 [TBL] [Abstract][Full Text] [Related]
8. Nonadjunctive Use of Continuous Glucose Monitoring for Diabetes Treatment Decisions. Castle JR; Jacobs PG J Diabetes Sci Technol; 2016 Sep; 10(5):1169-73. PubMed ID: 26880390 [TBL] [Abstract][Full Text] [Related]
9. Practical Considerations on the Use of Continuous Glucose Monitoring in Pediatrics and Older Adults and Nonadjunctive Use. Forlenza GP; Argento NB; Laffel LM Diabetes Technol Ther; 2017 Jun; 19(S3):S13-S20. PubMed ID: 28585878 [TBL] [Abstract][Full Text] [Related]
10. Prediction Quality of Glucose Trend Indicators in Two Continuous Tissue Glucose Monitoring Systems. Freckmann G; Link M; Westhoff A; Kamecke U; Pleus S; Haug C Diabetes Technol Ther; 2018 Aug; 20(8):550-556. PubMed ID: 30067409 [TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety comparison of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes: systematic review and meta-analysis. Wojciechowski P; Ryś P; Lipowska A; Gawęska M; Małecki MT Pol Arch Med Wewn; 2011 Oct; 121(10):333-43. PubMed ID: 22045094 [TBL] [Abstract][Full Text] [Related]
16. High incidence of hypoglycemia in stable insulin-treated type 2 diabetes mellitus: continuous glucose monitoring vs. self-monitored blood glucose. Observational prospective study. Pazos-Couselo M; García-López JM; González-Rodríguez M; Gude F; Mayán-Santos JM; Rodríguez-Segade S; Rodríguez-García J; Casanueva F Can J Diabetes; 2015 Oct; 39(5):428-33. PubMed ID: 26254702 [TBL] [Abstract][Full Text] [Related]
17. 2008 resource guide. New products. From drugs to continuous blood glucose monitors, the newest diabetes products are designed to make managing your condition easier and more convenient. Douglass K Diabetes Forecast; 2008 Jan; 61(1):RG2-5. PubMed ID: 18290286 [No Abstract] [Full Text] [Related]
18. FDA Advisory Panel Votes to Recommend Non-Adjunctive Use of Dexcom G5 Mobile CGM. Diabetes Technol Ther; 2016 Aug; 18(8):512-6. PubMed ID: 27472488 [No Abstract] [Full Text] [Related]
19. An Analysis of 2019 FDA Adverse Events for Two Insulin Pumps and Two Continuous Glucose Monitors. Krouwer JS J Diabetes Sci Technol; 2022 Jan; 16(1):228-232. PubMed ID: 32880188 [TBL] [Abstract][Full Text] [Related]